PARSIPPANY, NJ-Despite some concerns in the market that deals could slow down in the wake of the CMBS market collapse, the $110-million sale of Morris Corporate Center III at 400 Interpace Parkway here to institutional investors is evidence that trophy properties still sell, according to CB Richard Ellis.

The key to these deals is cold, hard cash. “These transactions that didn’t require financing,” get done, says Jeffrey Dunne, vice chairman of CBRE’s New York Institutional Group. Dunne, Kevin Welsh and Brian Schulz of CB Richard Ellis’ New York Institutional Group collaborated with Sam Buckley of CB Richard Ellis’ Saddle Brook Office. The buyer was advised by JP Morgan Asset Management.

CBRE is marketing a number of trophy and class A properties in the state, including Newport Tower, a 1.08-million-square-foot, 36-story office tower in Jersey City; Metropolitan Center in East Rutherford, NJ; and One Newark Center, a 416,429-square-foot office property in Newark. “Newport Tower is an all-cash deal,” Dunne notes. “The bidders for Metro Center will be institutional. So these will have nothing to do with CMBS.”

The 526,641-square-foot Morris Corporate Center III, situated on 27 acres in Morris Corporate Center, is 85% leased to tenants including the global headquarters of Ogilvy Commonhealth and the US headquarters of Watson Pharmaceutical. Built in 1989, it boasts a dramatic four-story atrium, granite fa

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM Digital Member, you’ll receive:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.